Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability.

Lejeune, F.J.

doi:10.1172/JCI16493

Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability.

Détails

Demande d'une copie

ID Serval

serval:BIB_25399

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability.

Périodique

Journal of Clinical Investigation

Auteur⸱e⸱s

Lejeune F.J.

ISSN

0021-9738 (Print)

ISSN-L

0021-9738

Statut éditorial

Publié

Date de publication

2002

Volume

110

Numéro

4

Pages

433-435

Langue

anglais

Notes

Publication types: Comment ; Journal Article
Publication Status: ppublish

Mots-clé

Animals, Antineoplastic Agents/administration &amp, dosage, Antineoplastic Agents/therapeutic use, Capillary Permeability/drug effects, Clinical Trials as Topic, Drug Delivery Systems, Drug Evaluation, Preclinical, Drug Therapy, Combination, Endothelial Growth Factors/pharmacology, Lymphokines/pharmacology, Mice, Neoplasms/blood supply, Neoplasms/drug therapy, Rats, Tumor Necrosis Factor-alpha/pharmacology, Tumor Necrosis Factor-alpha/therapeutic use, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors

OAI-PMH

oai:serval.unil.ch:BIB_25399

DOI

10.1172/JCI16493

Pubmed

12189235

Web of science

000177557400003

Open Access

Oui

Création de la notice

19/11/2007 13:21